Rapid and sustained improvement in skin pain with abrocitinib in adult and adolescent patients with moderate-to-severe atopic dermatitis

被引：0
|
作者：
Thyssen, J. P. [1 ]
Bewley, A. [2 ]
Stander, S. [3 ]
Kim, B. [4 ]
Biswas, P. [5 ]
DiBonaventura, M. [5 ]
Watkins, M. [5 ]
Alderfer, J. [6 ]
Guler, E. [7 ]
Silverberg, J. I. [8 ]
机构：
[1] Univ Copenhagen, Bispebjerg Hosp, Copenhagen, Denmark
[2] Barts Hlth NHS Trust, London, England
[3] Univ Hosp Munster, Ctr Chron Pruritus, Munster, Germany
[4] Washington Univ, Sch Med, St Louis, MO USA
[5] Pfizer Inc, New York, NY USA
[6] Pfizer Inc, Collegeville, PA USA
[7] Pfizer Inc, Istanbul, Turkey
[8] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2022年 / 186卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
639
引用
收藏
页码：E150 / E151
页数：2
相关论文
共 50 条
  • [1] Abrocitinib reduces skin pain in adolescent and adult patients with moderate-to-severe atopic dermatitis
    Thyssen, Jacob P.
    Bewley, Anthony
    Staender, Sonja
    Castro, Carla
    Misery, Laurent
    Kim, Brian
    Biswas, Pinaki
    Chan, Gary
    Myers, Daniela E.
    Watkins, Melissa
    Alderfer, Justine
    Guler, Erman
    Silverberg, Jonathan I.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E118 - E118
  • [2] Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
    Thyssen, Jacob P.
    Bewley, Anthony
    Staender, Sonja
    Castro, Carla
    Misery, Laurent
    Kim, Brian S.
    Biswas, Pinaki
    Chan, Gary
    Myers, Daniela E.
    Watkins, Melissa
    Alderfer, Justine
    Gueler, Erman
    Silverberg, Jonathan I.
    [J]. DERMATOLOGY, 2024, 240 (02) : 255 - 265
  • [3] Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, Emma
    Facheris, Paola
    Gomez-Arias, Pedro Jesus
    Del Duca, Ester
    Da Rosa, Joel Correa
    Weidinger, Stephan
    Bissonnette, Robert
    Armstrong, April W.
    Seneschal, Julien
    Eyerich, Kilian
    Estrada, Yeriel D.
    Bose, Swaroop N.
    Xu, Dan
    Chen, Allshine
    Tatulych, Svitlana
    Guler, Erman
    Chan, Gary
    Page, Karen M.
    Kerkmann, Urs
    [J]. ALLERGY, 2024, 79 (05) : 1258 - 1270
  • [4] Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Villegas, Susan C.
    Dima, Lorena
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2023, 30 (02) : E117 - E125
  • [5] An evaluation of abrocitinib for moderate-to-severe atopic dermatitis
    Labib, Angelina
    Yosipovitch, Gil
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (11) : 1107 - 1118
  • [6] Abrocitinib: a potential treatment for moderate-to-severe atopic dermatitis
    Nezamololama, Novin
    Crowley, Erika L.
    Gooderham, Melinda J.
    Papp, Kim
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (09) : 911 - 917
  • [7] Dupilumab treatment restores skin barrier function in adult and adolescent patients with moderate-to-severe atopic dermatitis
    Goleva, E.
    Bissonnette, R.
    Berdyshev, E.
    Jurvilliers, P.
    Agueusop, I.
    Praestgaard, A.
    Levit, N. A.
    Rossi, A.
    Zhang, A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S51 - S51
  • [8] Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis
    Edwards, Steven J.
    Karner, Charlotta
    Jhita, Tracey
    Barton, Samantha
    Marceniuk, Gemma
    Yiu, Zenas Z. N.
    Wittmann, Miriam
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2024, 28 (04)
  • [9] Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergies
    Schmid-Grendelmeier, Peter
    Gooderham, Melinda J.
    Hartmann, Karin
    Konstantinou, George N.
    Fellmann, Marc
    Koulias, Christopher
    Clibborn, Claire
    Biswas, Pinaki
    Brunner, Patrick M.
    [J]. ALLERGY, 2024, 79 (01) : 174 - 183
  • [10] ABROCITINIB MONOTHERAPY PROVIDES RAPID AND SUSTAINED ITCH IMPROVEMENT AT VARIOUS THRESHOLDS OF RESPONSE IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A POOLED ANALYSIS OF THREE RANDOMIZED TRIALS
    Kwatra, Shawn G.
    Guttman-Yassky, Emma
    Biswas, Pinaki
    Myers, Daniela E.
    Guler, Erman
    Gooderham, Melinda J.
    [J]. ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 21 - 21
12345